Advanz Adds Biosimilars Alliance With Alkem’s Enzene

Firms Strike Exclusive Partnership To Develop And Commercialize Rare Disease Drug

 
• By Dave Wallace
  
Rare Diseases spelled out in letter tiles
Advanz and Enzene are partnering on a biosimilar for a rare disease • Source: Shutterstock

More from Deals

More from Business